Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Delong

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Diabetes|June 9, 2019
Hybrid Insulin Peptides Are Autoantigens in Type 1 DiabetesRocky L Baker, Marynette Rihanek, Anita C Hohenstein, et al.
Diabetes|July 8, 2011
Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cellsThomas Delong, Rocky L Baker, Nichole Reisdorph, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2015
Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune DiabetesRocky L Baker, Brenda Bradley, Timothy A Wiles, et al.
Journal of Proteome Research|December 27, 2018
Identification of Hybrid Insulin Peptides (HIPs) in Mouse and Human Islets by Mass SpectrometryT. Aaron Wiles, Roger Powell, Cole Michel, et al.
Journal of Autoimmunity|November 19, 2013
Chromogranin A is a T cell antigen in human type 1 diabetesPeter A Gottlieb, Thomas Delong, Rocky L Baker, et al.
Frontiers in Immunology|August 29, 2022
Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetesJanet M Wenzlau, James E DiLisio, Gene Barbour, et al.
The Journal of Biological Chemistry|September 21, 2023
Hybrid insulin peptide isomers spontaneously form in pancreatic beta-cells from an aspartic anhydride intermediateSamantha A Crawford, Jason Groegler, Mylinh Dang, et al.
Diabetes|July 7, 2018
CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD MouseRocky L Baker, Braxton L Jamison, Timothy A Wiles, et al.
Diabetes|October 21, 2025
Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD MiceJason Groegler, Kaitlin Mangold, Kelli Nicholson, et al.
Frontiers in Immunology|June 11, 2021
Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin PeptideTimothy A Wiles, Anita Hohenstein, Laurie G Landry, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Diabetes|June 9, 2019
Hybrid Insulin Peptides Are Autoantigens in Type 1 DiabetesRocky L Baker, Marynette Rihanek, Anita C Hohenstein, et al.
Diabetes|July 8, 2011
Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cellsThomas Delong, Rocky L Baker, Nichole Reisdorph, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2015
Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune DiabetesRocky L Baker, Brenda Bradley, Timothy A Wiles, et al.
Journal of Proteome Research|December 27, 2018
Identification of Hybrid Insulin Peptides (HIPs) in Mouse and Human Islets by Mass SpectrometryT. Aaron Wiles, Roger Powell, Cole Michel, et al.
Journal of Autoimmunity|November 19, 2013
Chromogranin A is a T cell antigen in human type 1 diabetesPeter A Gottlieb, Thomas Delong, Rocky L Baker, et al.
Frontiers in Immunology|August 29, 2022
Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetesJanet M Wenzlau, James E DiLisio, Gene Barbour, et al.
The Journal of Biological Chemistry|September 21, 2023
Hybrid insulin peptide isomers spontaneously form in pancreatic beta-cells from an aspartic anhydride intermediateSamantha A Crawford, Jason Groegler, Mylinh Dang, et al.
Diabetes|July 7, 2018
CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD MouseRocky L Baker, Braxton L Jamison, Timothy A Wiles, et al.
Diabetes|October 21, 2025
Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD MiceJason Groegler, Kaitlin Mangold, Kelli Nicholson, et al.
Frontiers in Immunology|June 11, 2021
Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin PeptideTimothy A Wiles, Anita Hohenstein, Laurie G Landry, et al.
Pageof 3